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Background: Methodologists have proposed the formation of a good research question to initiate the process of
developing a research protocol that will guide the design, conduct and analysis of randomized controlled trials
(RCTs), and help improve the quality of reporting such studies. Five constituents of a good research question based
on the PICOT framing include: Population, Intervention, Comparator, Outcome, and Time-frame of outcome
assessment. The aim of this study was to analyze if the presence a structured research question, in PICOT format, in
RCTs used within a 2010 meta-analysis investigating the effectiveness of femoral nerve blocks after total knee
arthroplasty, is independently associated with improved quality of reporting.
Methods: Twenty-three RCT reports were assessed for the quality of reporting and then examined for the presence
of the five constituents of a structured research question based on PICOT framing. We created a PICOT score
(predictor variable), with a possible score between 0 and 5; one point for every constituent that was included. Our
outcome variable was a 14 point overall reporting quality score (OQRS) and a 3 point key methodological items
score (KMIS) based on the proper reporting of allocation concealment, blinding and numbers analysed using the
intention-to-treat principle. Both scores, OQRS and KMIS, are based on the Consolidated Standards for Reporting
Trials (CONSORT) statement. A multivariable regression analysis was conducted to determine if PICOT score was
independently associated with OQRS and KMIS.
Results: A completely structured PICOT score question was found in 2 of the 23 RCTs evaluated. Although not
statistically significant, higher PICOT was associated with higher OQRS [IRR: 1.267; 95% confidence interval (CI):
0.984, 1.630; p = 0.066] but not KMIS (1.061 (0.515, 2.188); 0.872). These results are comparable to those from a
similar study in terms of the direction and range of IRRs estimates. The results need to be interpreted cautiously
due to the small sample size.
Conclusions: This study showed that PICOT framing of a research question in anesthesia-related RCTs is not often
followed. Even though a statistically significant association with higher OQRS was not found, PICOT framing of a
research question is still an important attribute within all RCTs.* Correspondence: thabanl@mcmaster.ca
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In a previous study we recently completed, we found poor
overall quality of reporting [1] with randomized controlled
trials (RCTs) used in a femoral nerve block meta-analysis
[2]. We also identified considerable shortcoming in the
reporting of three key methodological items with these
RCTs. Most of the articles used in the meta-analysis came
from journals specialized in anesthesia. Poor quality of
reporting of RCTs is not exclusive to medical journals spe-
cialized in anesthesiology literature [3]. Similar findings
have been reported in major general medical journals and
subspecialty journals [4-15].
The lack of transparency in RCT reporting greatly
reduces the readers’ ability to judge the quality, validity
and reliability of the findings. It is difficult for the reader
to find information in a study when reporting of certain
qualities, especially those specified by the CONSORT
2010 statement [16], is done in a vague manner. Inad-
equate reporting and design of RCTs are associated with
bias, especially exaggerated intervention or treatment
effects that influence the interpretation of the findings
of RCTs in helping to develop clinical guidelines and in
being used for meta-analyses [16-18]. Formal critical
appraisal of trials is much more feasible with high qual-
ity of reporting of studies. This is because the published
paper is typically the primary gateway for most readers
to review RCTs. Although it is acceptable practice to
contact trial authors to obtain data and other study
details, the published article is the most accessible dis-
semination of the research that can be evaluated. The
Consolidated Standards of Reporting Trials (CON-
SORT) group have published updated guidelines in the
CONSORT 2010 statement that provide guidance on
the reporting of RCTs for authors and for the medical
publishing community at large [16-18]. This informa-
tion is available at http://www.consort-statement.org
[18]. Though there have been some significant improve-
ments in the quality of reporting since the CONSORT
statement publication in 2001, the quality of reporting
remains well below acceptable [10].
It is possible that certain predictor variables are associ-
ated with increased quality of reporting. Journal impact
factor, sample size and declared funding have been associ-
ated with better quality of RCT reporting [3,6,11,15,19,20].
Additionally, journal adoption of the CONSORT state-
ment has been associated with improved reporting of
RCTs [6,16,21-23]. Being able to identify variables which
can act as predictors for RCT quality of reporting could
better help medical practitioners to review current litera-
ture; including literature within anesthesia and pain man-
agement. In an observational study it was found that
journal publication, type of funding (particularly complete
industrial funding) and larger sample sizes were signifi-
cantly associated with a slightly better quality of reportingscore [3]. It is also possible that better framing of a re-
search question within an RCT can be independently
associated with better overall quality of reporting and
reporting of key methodologies, as were reported [24].
Methodologists have proposed the formation of a good
research question to maximize the process of developing
a research protocol, the study design and analytical as-
sessments needed for a study being undertaken [25,26].
A good question can aid an investigator tremendously
with choosing the correct methodology and strategy for
analysis, which in turn helps with appropriately answering
the primary research question [25-27]. A good research
question is structured and requires the specification of the
five constituents according to the PICOT approach [28].
These five constituents are: Population, Intervention,
Comparator, Outcome, and Time-frame of outcome as-
sessment (or commonly known by the acronym PICOT)
[25,26,28,29]. The PICOT approach is clear, concise and
easy to use in terms of framing all the components of a
research question [25]. The use of a properly structured
research question has been proposed to guide the
process of developing the research design and protocol
[25-27]. Our hypothesis is that a clear and complete re-
search question that contains all the PICOT elements
would spur better quality of reporting. The rationale
behind this hypothesis is that a more complete PICOT
question would drive the formation of a thorough re-
search methodology to fully address the specifics of the
research question and hence motivate detailed reporting
of what was done in the study. More evidence is still
needed to help the medical research community better
understand whether adherence to the PICOT approach
to developing a research question is associated with an in-
crease in the quality of reporting in research publications.
The aim of this observational study was to determine if
the presence of a structured research question in PICOT
format is independently associated with improved quality
of reporting of RCTs. In this study, we quantified quality
of reporting using a quality of reporting scoring system,
which is described in the Methods.
Methods
Study design
This is an observational study based on 23 RCTs used
in a meta-analysis to compare the analgesia outcomes of
femoral nerve block (FNB), with or without sciatic nerve
block, with epidural or patient controlled analgesia (PCA)
after total knee arthroplasty [2]. The 23 RCTs used in the
above mentioned meta-analysis were assessed in a previ-
ous study we conducted [1]. The following two things
were assessed for in this earlier study: 1) the quality of
reporting using a 15 point overall quality of reporting
score (OQRS) [1], 2) key methodological item score
(KMIS) using a 3 point score [1]. In this study, we went
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analysis [2] for a structured research question using the
PICOT format with a 5 point score. The first two quality
assessments of the 23 RCTs in the FNB meta-analysis [2],
OQRS and KMIS, were, as mentioned above, done in a
prior study that evaluated the quality of reporting and
reporting of methodological items as the outcome vari-
ables as well as four predictor variables hypothesized to
correlate with better outcomes (OQRS and KMIS) [1].
The data collected from this previous study was used to
examine if a structured research question using the
PICOT format is associated with better OQRS and KMIS
in the same 23 RCTs [1]. New data collected for this study
was in relation to variables needed to assess the presence
of a structured research question within the 23 RCTs,Table 1 Description of overall quality of reporting items
Item Descriptiona
1. Title or Abstract Identification as a randomized trial in t
and conclusions.
Introduction
2. Background Scientific background and explanation
3. Objectives Specific objectives or hypotheses.
Methods
4. Participants Eligibility criteria for participants.
Settings and locations where the data
5. Interventions The interventions for each group with
actually administered.
6. Outcomes* Completely defined pre-specified prim
were assessed.
7. Sample Size How sample size was determined.
When applicable, explanation of any in
8. Randomization:
Sequence Generation
Method used to generate the random
Type of randomisation; details of any r
9. Randomization:
Implementation
There is mention of: Who generated th
assigned participants to interventions?
10. Statistical Methods Statistical methods used to compare g
Methods for additional analyses, such a
Results
11. Participants Flow For each group, the numbers of partic
were analysed for the primary outcom
For each group, losses and exclusions
12. Recruitment Dates defining the periods of recruitm
Why the trial ended or was stopped.
13. Baseline Data A table showing baseline demographic
14. Outcomes and
Estimates
For each primary and secondary outco
precision (such as 95% confidence inte
For binary outcomes, presentation of b
15. Harms All important harms or unintended effe
*For the purpose of this study, our original 15 point OQRS was reduced to a 14 poi
and this was assessed as part of our PICOT score instead.
aThe descriptions of the reporting items were taken directly from the CONSORT 201using the PICOT format (Population, Intervention, Com-
parator, Outcome, Timeframe) with a 5 point score (score
out of 5, with a possible range of score from 0 to 5 inclu-
sively). For the purpose of this study, our original 15 point
OQRS was reduced to a 14 point score because one of the
15 items we initially assessed for in our previous study [1]
was “objectives” and this was in part assessed as part of
our PICOT score (item 6 on Table 1). Much of our study’s
method and protocol design models another study that
also looked at the association between a PICOT structured
research question and quality of reporting and reporting
of key methodological items in RCTs, separately [24]. We
found this study by Rios et al. [24] to have a sound method-
ology for effectively evaluating important variables needed
to assess the quality of reporting, key methodological itemshe title and a structured summary of the trial design, methods, results,
of rationale.
were collected
sufficient details to allow replication, including how and when they were
ary and secondary outcome measures, including how and when they
terim analyses and stopping guidelines.
allocation sequence
estriction (such as blocking and block size).
e random allocation sequence, who enrolled participants, and who
roups for primary and secondary outcomes.
s subgroup analyses and adjusted analyses.
ipants who were randomly assigned, received intended treatment, and
e.
after randomisation, together with reasons.
ent and follow-up
and clinical characteristics for each group.
me, results for each group, and the estimated effect size and its
rval).
oth absolute and relative effect sizes is recommended.
cts in each group
nt score because one of the 15 items we initially assessed for was “objectives”
0 [16].
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PICOT format.
Rating of overall reporting quality and key
methodological items
In our previous study [1] we defined the quality of
reporting as the extent which the rationale, design, con-
duct and analysis of each RCT evaluated was reported [1].
We did this by using 15 items from the 2010 CONSORT
statement. The 15 items evaluated are reported in Table 1.
These 15 items were selected for in our previous study [1]
because the literature indicates that an absence in report-
ing these items is associated with a higher level of bias
[16]. CONSORT items under “discussion” were excluded
as we deemed them to be too subjective to assess. An
OQRS, with 15 items in total (possible score from 1 to
15), was established. For scoring purposes, each of the 15
items was scored 1 if it was reported appropriately and
0 if it was not evidently stated or completely not stated.
This score was reduced to 14 for this study for the
reason mentioned above.
Three methodological items, which are a part of the
CONSORT statement, were also excluded from our 14
point OQRS for a separate assessment to create the KMIS.
These three methodological items are: 1) appropriate con-
cealment of allocation, 2) blinding, and 3) numbers ana-
lysed (or known as the intention-to-treat principle). They
were assessed separately because they are highly important
in avoiding bias and misrepresentation of the treatment
effect estimates [30-35]. Each of the three mentioned
methodological items were given a score of 1 if the
method was appropriate and 0 if it was inappropriate or
vaguely reported. A combined KMIS was calculated for
each RCT by adding the scores of each methodological
item with a possible KMIS ranging from 0 to 3 [1].
We considered allocation concealment to be done ap-
propriately if centralized randomization, coded, numbered
vehicles or sealed, opaque, and sequentially numbered en-
velopes were reported [36]. For blinding, in trials where
there were no barriers to blind groups, at least two groups
had to be explicitly reported as blinded to fulfil this item’s
criteria. In instances where blinding was not feasible, we
considered blinding to have been appropriately done if at
least one group was unambiguously reported as blinded
[3,37,38]. In our previous study [1], numbers analysed
based on intention-to-treat (ITT) analysis was defined as a
study that included all participants randomized into an
RCT and the trials statistical analysis regardless if: 1) the
intervention was administered, 2) if patients fulfilled
the study entry criteria and 3) if patients withdrew from
the trial, or there were treatment deviations from protocol
[37,39-41]. The meaning of ITT has been interpreted
differently by various RCTs, however the Cochrane
Handbook has compiled evidence specifying that thedefinition we used averts a biased treatment effect and
is a practical way to understand the effects of a clinical
intervention [41,42].
As described previously, a number of predictor variables
have been shown to have a positive association with the
reporting quality of RCTs [3,6,11,15,16,19-23]. The four
predictor variables we used were sample size, impact
factor, funding reported and journal adoption of the
CONSORT statement at the time of our data abstrac-
tion. This step, as already mentioned above, was done in
our previous study that included the 23 RCTs used in
this study [1]. Sample size was defined as number of
patients randomized in each trial. The impact factor of
the journal refers to an index number that is assigned to
a journal that is catalogued with Thomson Reuter’s
Journal Citation Reports. This index number is calculated
by Thomson Reuters [43] and is a ratio that describes the
frequency that an “average article” in a particular journal
has been cited in a specific year or period of time [43].
Funding reported was defined as funding that was men-
tioned and provided for the undertaking of the study.
Journal adoption of the CONSORT statement at the time
of our data abstraction was defined as the journal (within
which that RCT is published) endorsing, enforcing or
encouraging the use of the CONSORT statement for
manuscript submissions.
The rating of the research question in PICOT format
We identified one paragraph from the introduction or
methods section that we found best stated the primary re-
search question, hypothesis or objective. To accomplish
this, reviewers read both the introduction and methods
section careful to identify the paragraph which best
described the aims of the study. That paragraph was
then reread to see which PICOT components were
mentioned. We chose one paragraph because according
to the PICOT framework, a research question should be
cohesive and put together in a single statement [25].
One paragraph should be sufficient to include all the
components of a PICOT question. This enables the
reader to clearly understand the intention behind the
study without having to repeatedly sift through different
sections of the paper to piece together the entire research
question. In those paragraphs, we evaluated the framing of
the research question, regardless if it was in the form of
a research question, objective or hypothesis. We then
evaluated if the 5 elements of a research question were
present in that paragraph. The 5 elements were, the
type of population or patient pertinent to the question,
the intervention, the comparative intervention, the out-
come of interest, and the time allocated for measuring
the outcome or outcomes of interest (P, I, C, O and T
respectively). We scored each PICOT element with a 1
if it was explicitly stated and 0 if it was absent. In the
Table 2 Frequency of description of each PICOT element
Element of the
research question
All articles (n = 23)
Count 95% CI*
P: Patients 21 (18, 23)
I: Invention 23 (15, 23)
C: Comparator 19 (15, 22)
O: Outcome 12 (7, 17)
T: Timeframe 4 (1, 8)
Complete PICOT 2 (0, 5)
CI: Confidence Interval.
*For item that has non-zero event, the 95% CI was approximated by assuming
the number of events followed a Binomial distribution; for item that has zero
event, the 95% CI was approximated by the rule of three [44].
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tween 0 and 5 inclusively. This scoring system for the
PICOT was used in a study done by Rios et al. [24]. The
score represents how complete the primary research
question is within the evaluated RCT. We decided to
qualify a study as providing a structured research ques-
tion only if the five elements (Complete PICOT) were
present in the description of the primary research ques-
tion, the study objectives or in a declared research hy-
pothesis. RCTs that did not describe all 5 elements
(Incomplete PICOT) were deemed to not have included
a structured research question.
Hypotheses
We hypothesized that higher PICOT scores will be asso-
ciated with better quality of reporting as judged by the
CONSORT completeness of reporting based on the
OQRS and KMIS score system used in this study.
Data abstraction
We used an Excel standardized data abstraction form to
extract data from each article. Two reviewers (VJBD and
SZ) were blinded to each other’s ratings and extracted
data independently. When the research question was
rated, the reviewers were blinded to the OQRS and score
for the KMIS for each article that was done for a previous
study [1]. Any disagreements were resolved through con-
sensus. Kappa statistics were used to measure the inter
rater agreement for each of the 5 PICOT elements of the
research question. The Kappa statistics for the OQRS and
the KMIS have been reported in our previous study [1].
Statistical analysis
Categorical data were reported as number of counts. Each
PICOT element was coded as a binary variable (1 = the
element was clearly addressed in the research question
and 0 = it was not clearly addressed in the research
question). The number of RCTs that explicitly stated
the PICOT element and the associated 95% confidence
interval were calculated. The PICOT score was computed
as the sum of the 5 individual elements and ranged from 0
to 5 inclusively. For the element that had a “zero” count or
“full” counts, for instance when none of or all of the
included trials reported that PICOT element, the 95% CI
was calculated by adopting the rule of three [44]. This
means that if none of n individuals within a PICOT
element (i.e. one of the PICOT elements: P. I, C, O or
T) showed the event that we were interested in, we
could be 95% confident that the chance of this event
occurring is at most 3 in n [45]. For the other PICOT
elements, the 95% CI of the count was calculated by
making the assumption that the number of RCTs that
clearly stated the element followed a binomial distribu-
tion. The probability that an RCT had clearly stated theelement was set to be the observed probability in the
sample. The Cohen’s Kappa (κ) statistics were used to
calculate the chance-adjusted agreement between the 2
raters for every PICOT element. Agreement was inter-
preted as poor if κ ≤ 0.2, fair if 0.21 ≤ κ ≤ 0.4, moderate
if 0.41 ≤ κ ≤0.6, substantial if 0.61 ≤ κ ≤ 0.8 and good if
κ > 0.8 [45].
A multivariable regression analysis, where the OQRS
score was the outcome variable, was done to determine
if a higher PICOT score was independently associated
with a better OQRS. We included funding reported,
journal adoption of the CONSORT statement at the time
of data abstraction, sample size and the impact factor of
the journal the RCTs were from as covariates for the
OQRS. Here these variables were adjusted as covariates
in the model. The sample size was transformed by the
logarithm function with base 10 to improve interpretabil-
ity. The OQRS (discrete, ranged from 0–14) was assumed
to follow a Poisson distribution. The incidence rate ratio
(IRR) was used to state the results of the analysis. The
same method was used for the regression analyses with
the KMIS as the outcome variable. Variables were con-
sidered to be statistically significant at alpha = 0.05. Re-
gression analyses were also conducted to explore which
individual PICOT elements were more associated with a
better OQRS with adjustment of confounding variables.
We did not adjust the overall level of significance for
multiple testing because these analyses were primarily
exploratory [46]. SPSS© 19.0.0.0 (IBM Corporation,
2010) was used to perform the statistical analyses.
Results
Rating of the research question using the PICOT
framework
For the rating of the individual elements of the PICOT
research question, the κ inter-rater agreement estimate
using Cohen’s Kappa varied from 0.623 to 1. The median
PICOT score was 3 (IQR = 1). The percentage of articles
that described each PICOT element of a research ques-
tion is in Table 2. Patients, intervention and comparators
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scribed the study’s time frame and less than 55% of the
studies adequately described outcomes within the research
question in that there was mention of the primary and
secondary outcomes of the study. A complete PICOT
structured research question was present in 2 out of the
23 RCTs evaluated.
Factors associated between PICOT framing of a research
question and quality of reporting and key
methodological item reporting
Table 3 and 4 display the results of the multivariable
analysis for the factors associated with the OQRS and the
KMIS, respectively. After adjusting for sample size, impact
factor, journal adoption of the CONSORT statement at
the time of our data abstraction and funding reported, a
higher PICOT score was not significantly associated
with a higher OQRS (Table 3) or KMIS (Table 4) in the
multivariable analysis. The model however did show a
trend for the PICOT score and OQRS but not KMIS. At
each point or one unit increase in the PICOT score
there was a detected 26.7% increase in the number of
quality of reporting items discussed, on average. We did
not find a significant association between any one of the
PICOT items and the outcomes OQRS and KMIS
(Table 5). In addition, each of the four covariates: sample
size, impact factor, journal adoption of the CONSORT
statement, and funding reported were not significantly
associated with the outcomes OQRS and KMIS in the
univariate analyses. The results of the univariate analysis
are reported in Table 3 and Table 4.
Discussion
We assessed the use of the PICOT framing of a research
question in 23 RCTs used within a meta-analysis from
2010 assessing the use of FNB in improving analgesia
outcome after total knee arthroplasty [2]. We found that
the framing of the research question was usually incom-
plete, ambiguous and inconsistently written in either the
introduction or methods section of the study. Sometimes





Journal adopted CONSORT Statement at the time of data collection. 0.89
Funding reported 1.24
CI: Confidence Interval; IRR: Incidence Rate Ratio.
aMaximum Possible Score for the Overall Quality of Reporting Score = 14.
bThe sample size variable was log(10) transformed. The value is an expression of th
in the log scale.introduction and methods section. Only 2 out of the 23
RCTs had a completely structured research question
using the PICOT format. This finding is not uncommon
as two studies have previously shown poor PICOT
framing of research question among RCTs [24,25],
where in one study a structured research question was
present in only 33.7% of the reports assessed [24].
From our literature search this is the second study to
look at the association between PICOT framing of a re-
search question and the overall quality of reporting and
reporting of key methodological items of RCTs. This paper
is unique in that it reviews RCT literature in anesthesia
and studies used in a meta-analysis. Our results did not
show a significant association between the completeness
of the PICOT framing of a research question and OQRS
and KMIS using the alpha value we set for significance
(set as p < 0.05). Although we would attribute this to our
small sample size, the results should be interpreted with
caution. We did however uncover trends and tried to
make comparisons to other studies using PICOT framing
or some analogous predictor variable for OQRS or KMIS.
After a review of the literature one study was found
that showed an association between PICOT framing of
a research question with overall reporting quality and
reporting of key methodological items and that reported
findings in a statistical and numerical approach that could
be used for a trend comparison [24]. We were also able
to compare the sample size predictor variable from this
study.
For the OQRS outcome variable there were a few
trends noted. For PICOT framing of a research question
(predictor variable) the direction, magnitude and range
of the effect was similar to the comparator study [24].
For the predictor variable of sample size, our direction
and magnitude of the effect was different, however our
range from our 95% confidence interval (CI) encompassed
the incidence rate ratio (IRR) of the comparator study.
Again, as mentioned previously, this is likely attributed to
our small sample size.
For the KMIS outcome variable we also found some
trends. For both predictor variables, PICOT framing of aof Reporting Score (OQRS)a
Univariate analysis Multi-variable analysis
95% CI P value IRR 95% CI P value
9 (0.835, 1.608) 0.378 1.267 (0.984, 1.630) 0.066
8 (0.991, 1.006) 0.681 0.546 (0.199, 1.498) 0.240
9 (0.744, 1.209) 0.67 0.915 (0.690, 1.212) 0.535
8 (0.646, 1.248) 0.521 1.063 (0.721, 1.568) 0.757
1 (0.817, 1.887) 0.312 1.147 (0.722, 1.823) 0.562
e change in the average of the OQRS due to one unit increase in sample size
Table 4 Association between PICOT score and Key Methodological Items Score (KMIS)a
Univariate analysis Multi-variable analysis
Predictor Variable IRR 95% CI P value IRR 95% CI P value
PICOT 1.007 (0.987, 1.027) 0.492 1.061 (0.515, 2.188) 0.872
Sample Sizeb 1.746 (0.677, 4.504) 0.249 2.139 (0.126, 36.243) 0.598
Impact Factor 1.601 (0.784, 3.269) 0.196 2.037 (0.739, 5.614) 0.169
Journal adopted CONSORT Statement at the time of data collection. 0.909 (0.359, 2.303) 0.841 0.528 (0.147, 1.900) 0.329
Funding reported 2.051 (0.731, 5.754) 0.172 1.697 (0.533, 5.408) 0.371
CI: Confidence Interval; IRR: Incidence Rate Ratio.
aMaximum Possible Score for the Key Methodological Items Score = 3.
bThe sample size variable was log(10) transformed. The value is an expression of the change in the average of the KMIS due to one unit increase in sample size in
the log scale.
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tude and range of the effect was similar to the comparator
study. Our results are promising because in spite of our
limitation with our own RCT sample size we still could
show trends indicating a positive association between
proper and complete PICOT framing of a research ques-
tion and OQRS but not KMIS.
The noted association with the completeness of the
PICOT framing of a research question and the quality of
reporting is important [24] as it suggests that the theoret-
ical reasoning behind systematically structuring a research
question has practical and tangible applications in improv-
ing study design and transparency in the actual reporting.
A desirable research question is one that is framed to con-
structively aid knowledge acquisition [47]. The question’s
framing itself plays an important role in methodically and
systematically clarifying the thought process needed to
assess required outcomes and the purpose and benefit
of the question itself [47,48]. A structured research
question is focused as questions too broad will likely
lack methodological rigor [47,48]. The PICOT method
is a good approach as its five constituents help to focus
a question and incite thoughts about rigorous meth-
odological design and the feasibility of answering the
question [25,48,49].
Limitations
It is important to note the various limitations in our study,
some background on the effect these drawbacks have and
any future improvements. One important limitation of our
study is that there is no standard instrument to evaluate
the quality of reporting of RCTs. The quality scores
attained from our evaluation instrument are not validated.
Most scales used to evaluate the quality of reporting have
not been thoroughly developed or tested as a gold stand-
ard (external criterion) is needed in order to compare for
validity and reliability of the scale developed [50]. Because
a gold standard does not currently exist for reporting the
quality of RCTs, scales used for this purpose of reporting
quality are only assessed based on an accepted theoretical
model [50,51]. There has not been a single scale shown atbeing superior at measuring the quality of reporting allud-
ing that dissimilar attributes in reporting are probably be-
ing measured [52,53] or there is, as we infer, an element of
subjectivity in the way the scale allows for assessment.
Quality scores based on checklists, such as the ones in
our study, may also be unreliable and could introduce
bias [52,53]. Scores were shown to differ contingent on
the scoring system that was used [52,53]. The benefit of
using the evaluation instrument we used is that it is
based on the CONSORT checklist criteria from the
2010 CONSORT statement and the statement itself is
widely recognized by journals and editorial groups [18].
The items we assessed for in this study are founded on
well recognized features expected in the reporting and
conduct of RCTs [18]. Another potential limitation of
this study is that some PICOT items may be directly
related to the CONSORT statement items used to create
the OQRS. For instance, PICOT items “Population”,
“Intervention” and “Outcome” may be directly related
to the CONSORT items “Participants”, “Intervention”
and “Outcomes”. This may have a possible effect on the
analysis. To address this possible effect we looked at the
associations between the individual PICOT items and
the outcomes used in this study (Overall Quality of
Reporting Score (OQRS) and the Key Methodological
Items Score (KMIS)). The results of this analysis are in
Table 5. None of the potential associations with the in-
dividual PICOT items were statistically significant—
which may also be due to low statistical power. In the
future it might be best to assess each individual item in
our checklists for the OQRS and KMIS against the com-
pleteness of the PICOT structured research question [17]
and substantially increase our sample size of RCTs to
improve the power needed to detect a difference. Lastly,
another possible limitation is the fact that the RCTs that
we evaluated mostly come from anesthesia specialized
journals, which may appear to reduce the generalizability
of our findings. However, the generalizability would not be
affected by this because the relationship between PICOT
and the quality of reporting is not expected to be different
depending on the field from which the RCTs come from.
Table 5 Association between individual PICOT items and the outcomes (Overall Quality of Reporting Score (OQRS)a
and the Key Methodological Items Score (KMIS)b)
Overall quality of reporting score (OQRS)a
Predictor variable IRR 95% CI P value
Population
P – Population 1.427 (0.566, 3.593) 0.451
Sample sizec 0.737 (0.287, 1.894) 0.527
Impact factor 0.939 (0.714, 1.236) 0.655
Journal adopted CONSORT Statement at the time of data collection. 0.954 (0.665, 1.368) 0.796
Funding reported 1.267 (0.818, 1.962) 0.290
Control
C - Control 1.459 (0.855, 2.490) 0.166
Sample sizec 0.679 (0.264, 1.750) 0.423
Impact factor 0.921 (0.699, 1.212) 0.556
Journal adopted CONSORT Statement at the time of data collection. 0.871 (0.604, 1.256) 0.458
Funding reported 1.448 (0.910, 2.304) 0.119
Outcome
O - Outcome 1.099 (0.726, 1.664) 0.655
Sample sizec 0.753 (0.293, 1.939) 0.557
Impact factor 0.915 (0.691, 1.212) 0.536
Journal adopted CONSORT Statement at the time of data collection. 0.972 (0.648, 1.458) 0.891
Funding reported 1.236 (0.762, 2.008) 0.391
Timeframe
T- Timeframe 1.320 (0.818, 2.131) 0.256
Sample sizec 0.611 (0.215, 1.733) 0.354
Impact factor 0.935 (0.708, 1.236) 0.638
Journal adopted CONSORT Statement at the time of data collection. 0.987 (0.676, 1.440) 0.945
Funding reported 1.234 (0.790, 1.928) 0.355
Key methodological items score (KMIS)b
Population
P- Population 0.726 (0.085, 6.216) 0.770
Sample sizec 2.548 (0.194, 33.401) 0.476
Impact factor 2.032 (0.732, 5.641) 0.173
Journal adopted CONSORT Statement at the time of data collection. 0.496 (0.136, 1.812) 0.289
Funding reported 1.811 (0.624, 5.260) 0.275
Control
C - Control 2.068 (0.386, 11.076) 0.396
Sample sizec 1.674 (0.127, 22.148) 0.696
Impact factor 1.995 (0.732, 5.436) 0.177
Journal adopted CONSORT Statement at the time of data collection. 0.457 (0.127, 1.641) 0.230
Funding reported 2.130 (0.665, 6.825) 0.203
Outcome
O - Outcome 0.948 (0.277, 3.245) 0.933
Sample sizec 2.418 (0.189, 30.923) 0.497
Impact factor 2.017 (0.744, 5.470) 0.168
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Table 5 Association between individual PICOT items and the outcomes (Overall Quality of Reporting Score (OQRS)a
and the Key Methodological Items Score (KMIS)b) (Continued)
Journal adopted CONSORT Statement at the time of data collection. 0.507 (0.134, 1.919) 0.317
Funding reported 1.823 (0.506, 6.569) 0.359
Timeframe
T - Timeframe 0.799 (0.187, 3.403) 0.761
Sample sizec 2.858 (0.181, 45.059) 0.455
Impact factor 1.973 (0.725, 5.371) 0.184
Journal adopted CONSORT Statement at the time of data collection. 0.514 (0.151, 1.755) 0.288
Funding reported 1.872 (0.618, 5.668) 0.267
CI: Confidence Interval; IRR: Incidence Rate Ratio.
aMaximum Possible Score for the Overall Quality of Reporting Score (OQRS) = 14.
bMaximum Possible Score for the Key Methodological Items Score = 3.
cThe sample size variable was log(10) transformed. The value is an expression of the change in the average of the OQRS due to one unit increase in sample size
in the log scale.
No individual analysis of the Intervention (I) component of the PICOT score was done because all studies reported their intervention when they described their
research question.
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PICOT framing of a research question and OQRS and
KMIS within a meta-analysis that has the potential to in-
form clinical practice. To increase the generalizability, a
study of similar design with a much larger sample size of
RCTs would be needed. Regardless of these noted limita-
tions, this study brings value because it shows that proper
and clear PICOT framing of a research question is still
limited. We also showed that we have internal validity due
to our good inter-rater reliability correlation between two
reviewers who independently assessed the quality of
reporting, key methodological items and PICOT framing
of the research question. Our results should be interpreted
with caution as a small sample size was used and we did
not adjust for multiple testing in our analysis as our
analyses were only exploratory.
Conclusions
This study showed that PICOT framing of a research
question in anesthesia related RCTs are incompletely
structured with only two RCTs having a completely
structured research question out of the 23 RCTs
assessed. Although we did not find a statistically signifi-
cant association between the completeness of the PICOT
structured research question and OQRS and KMIS, our
comparison with another study [24] showed strong trends
between PICOT and OQRS but not KMIS. We are aware
that our sample size is small and that cautious interpret-
ation of the results should be made due to this. Poor
overall quality of reporting does not mean there is poor
methodological rigor within RCTs as some or even
many features of a trial may not be adequately reported
unless a protocol is assessed in conjunction. However,
protocols are not as easily accessible and researchers
when publishing should be aware that the publication of
a study is a surrogate when assessing for study quality.The outcome of this study for researchers is that the
proper and complete PICOT structure of a research
question is an important attribute to all studies as it
helps to indirectly improve reporting by initiating the
thought process needed for thorough study design and
management.
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